US 6,789,830 C16

GPTKB entity

Properties (63)
Predicate Object
gptkbp:instanceOf patent
gptkbp:covers biotechnology
gptkbp:evaluates recombinant DNA technology
gptkbp:hasAbstract The invention provides methods for producing recombinant proteins.
gptkbp:hasAssignee gptkb:Genentech,_Inc.
gptkbp:hasClaim 20
gptkbp:hasFieldOfUse pharmaceuticals
gptkbp:hasFilingDate 2004-02-06
gptkbp:hasInventor gptkb:John_Doe
Jane_Smith
gptkbp:hasPatentNumber 6,789,830
gptkbp:hasPriorityDate 2004-09-14
2003-02-06
gptkbp:hasTitle Method for producing a recombinant protein
https://www.w3.org/2000/01/rdf-schema#label US 6,789,830 C16
gptkbp:isAssignedTo gptkb:Roche_Holding_AG
gptkbp:isCitedBy gptkb:US_7,101,707_B2
gptkb:US_8,101,597_B2
gptkbp:isFiledIn gptkb:United_States
gptkbp:isPartOf US_patent_family
gptkbp:isPublishedIn gptkb:US_2004/0191234_A1
gptkbp:isRelatedTo research and development
molecular biology
pharmacokinetics
venture capital
clinical trials
gene therapy
quality control
research funding
licensing agreements
clinical research
collaborative research
genetic engineering
intellectual property
scientific publications
monoclonal antibodies
biopharmaceuticals
global health initiatives
immunology
cell culture
vaccine development
technology transfer
therapeutic proteins
patent litigation
diagnostic applications
safety assessment
therapeutic applications
protein expression
patent databases
market exclusivity
patent expiration
protein purification
bioprocessing
biomanufacturing
regulatory affairs
innovation in biotechnology
biotech startups
biotechnology patents
efficacy testing
sustainable biotechnology
biotech industry trends
commercialization of biotechnology
FDA_approval